Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06746285Not ApplicableActive Not Recruiting

Evaluating the Impact of Synbiotic Supplementation on Infants and Toddlers

Role: lead

NCT06091813Not ApplicableCompleted

Ambrosia: Evaluating the Effects of a Food-As-Medicine Platform on Gut Microbiome Composition and Metabolism

Role: lead

NCT04770649Terminated

Vaccine Observation to Include All Communities for Equitable Science

Role: lead

NCT05472688Active Not Recruiting

My Baby Biome: Infant Stool Samples for Microbiome Health (MBB)

Role: lead

NCT04638751Recruiting

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

Role: lead

NCT04291755Recruiting

Development and Analysis of a Stool Bank for Cancer Patients

Role: lead

All 6 trials loaded